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Summarv 
Tetrapeptides of pdmary sequence Tyr-X-Phe-YNH 2, where X Is D-Cys or D-Pen 
(peniclllamlne) and where Y Is D-Pen or L-Pen, were prepared and were cyclized via the side 
chain sulfurs of residues 2 and 4 to disulfide or dithioether-contalning analogs. These 
peptldes are related to previously reported peniclllamine-contalning pentapaptide enkephalin 
analogs but lack the central glycine residue of the latter and were designed to assess the 
effect of decreased dng size on oploid activity. Binding affinities of the tetrapeptides were 
determined to both /J and ~; oploid receptors. Binding affinity and selectivity in the 
tetrapaptlde sed~s were observed to be highly dependent on pdmary sequence. For 
example, L-Pen a r~.ogs dismayed low affinity and were nonselective, while the 
corresponding D-Pen diastereomers were of variable affinity and higher selectivity. Among 
the latter compounds were examples of potent analogs in which selectivity shifted from 6 
selective to/~ selective as the dng size was increased. The relatively high binding affinity and 
6 receptor selectivity observed with one of the carboxamide terminal disulfide analogs led to 
the synthesis of the corresponding carbox~ic acid terminal, Tyr-D-Cys-Phe-D-PenOH. This 
anal,~)g displayed 6 receptor binding selectivity similar to that of the standard 6 ligand, [D- 
Pen'~,D-Pen"]enkephalin (DPDPE), and was found to have a 3.5-fold higher binding affinity 
than DPDPE. All the tetrapeptides were further evaluated in the isolated mouse vas deferens 
( mvd ) assay and all displayed opioid agonist activity. In general, tetrapaptide potencies in 
the mouse vas deferens correlated well with binding affinities but were somewhat lower. 
Receptor selectivity in the mvd, assessed by examining the effect of opioid antagonists on 
the tetrapaptide concentration-effect curves, was similar to that determined in the binding 
studies. 




in which X = D-Cys or D-Pen 
Y = D(or L)-Cys or D(or L)-Pen 
where Pen, peniclllamlne, Is /9,/]-dimethylcystelne. These analogs, which are conformatlonally restricted 
because of the Imposed cycllzation through the side chain sulfurs and are further restdcted because of the 
dgldlzing effect of the penlcillamlne gem dimethyl groups (1), are notable for their high degree of selectivity 
0024-3205/88 $3.00 + .00 
Copyright (c) 1988 Pergamon Press plc 
1014 Cyclic Oplold Tetrapeptldes Vol. 43, No. 12, 1988 
for the ~ oploid r e . o r .  TJle bLs-panlcHlamlne analogs within this series, [D-Pen 2, D-PenS]enkephalin 
(DPDPE) and [D-Pen , L-Pen"]enkephalln (DPLPE) display the highest selectivity y~  report~:l for the 
receptor, while t ho~_ analog R wtth a single panlclllamlne residue, such as [D-Pen L, L-Cys"]enkephalin 
(DPLCE) and [D-Cys , D-Pen"]enkephalln (DCDPE), are less selective but are more potent. More recently 
we have examined the effect of dog size on opiold activtty for the bis-penicglamlne analogs by means of the 
dlthloether-contalnlng eades: 
$ (CH2) n S 
I I 
H-Tyr-D-Pen-Gly-Phe-D ( o r  L) -PenOH 
In this series ~ receptor binding affinity and selectivity were observed to decrease with increasing ring size 
(4) .  
Schiller and coworkers have reported a series of smaller, cyclic des-Gly 3 enkephalin tetrapeptides in 
which cycllzatlon is effected by amlde bond formation via side chain functions of residues 2 and 4 (5,6). 
Within this series are members which display considerable /= oploid receptor selectivity resulting primarily 
from reduced 6 receptor affinity. In view of this finding and our studies on expanded rtng size In the 
pentapaptlde series, we undertook an Investigation of the effect of ring contraction on oploid recep(or affinity 
and selectivity In a series of des-Gly ° disulfide- and dlthloether-contalnlng tetrapaptides of general structure: 
-(CH2)n~ 
H - Tyr - X - Phe - Y - NH 2 (or -OH) 
where X = D-Cys or D-Pen 
Y = D-(or L-)Pen 
n = 0 , 1 , 2 , 3  
Several analogs In this series have Interesting oploid receptor binding profiles. Particularly noteworthy 
among these Is an analog which exhlbCs higher ~ receptor affinity than the bis-penicHlamine enkephalins 
while rnalntalnlng comparable selectivity. 
Methods 
Peotlde synthesis. All pep(Ides reported here were prepared by solid phase methods slmgar to those 
p r ~  described (2,4,7). Chloromethylated poh/styrene (Merrlflald) resin crossllnked with 1% 
dMnylbenzene was used for the synthesis of peptides with carboxy terminal carboxylic acid functions, while 
p-methyll:~nzhydry4amlne resin was used for the synthesis of carboxamide terminal pep(ides, t- 
But~oxycartx:~yl protection of ~.-amlno functions was used throughout, while S-p-methylbenzyt protection 
was used for the labile side chain sulfurs of Cys and Pen. In all cases the linear free-sulfhydryl containing 
paptides were generated by treatment of the paptide-resin with anhydrous HF In the preset'me of 5% anlscle 
and 5% dlthlo~hane, as has been previously descdbed (2). Pdor to cyclizatlon, the linear, free sulfhydryt- 
containing pap(ides were purified by reverse phase-high performance liquid chromatography (RP-HPLC) on 
a Vydac 218TP C-18 column (2.5 x 22cm) using the solvent system 0.1% trlfluoroacetlc acid ('I'FA) In H20 / 
0.1% TFA In acetonltrle. A gradient of 10-50% organic component over a course of 40 mln was employed for 
all purifications. Disulfide containing analogs were prepared by treating an aqueous solution ( pH 8.5 ) of the 
corresponding free sulfhydry|-contalning species with K3Fe(CN)6 (2), while dlthloether-containlng analogs 
were obtained by treating a dlfute solution of the free suil'nydr~-contalning peptide in dimethyt formamide 
with potassium tert-butoxide followed by addition of the appropriate alkyl dibromide (4). Disuffide and 
dltldoether-containlng pep¢ides were purified by RP-HPLC as described above. Purity of the final product 
paptldes was assessed by analytical HPLC monitored at 280nm and at 23Ohm. All pap(ides were >98% pure 
by rids measure. Analytical evaluation of the final paptides also Included testing with 5,5'-dithiobis-(2- 
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nltrobenzolc acid) to detect the presence of free sulfhydryl groups (8). Final confim~tion of the putative 
structures was ol0talnad by fast atom bombardment-mass spectrometry which ytelded the appropriate 
molecular weights for all of the peptldes. 
Receotor bindlrm essava. The binding assays, based on the displacement by the test compounds of 
redldebelled sufentanl ~ Ilgand) or DPDPE (~ I~nd) In cerebral membranes from rat brain, were p e r f ~  
as previously described (9,10). Briefly, the assay mixture, containing membrane suspan~on In 50mM Trls 
buffer (oH 7.4), 150mM NaCI, the radlofabeged liga~l and the test compound, wa~ incubated to reach 
bindlog equilibrium (40min for assays using 0.5nM [°H]sufentanll; 60min for 1.5nM ['~H]DPDPE) at 25°C. 
Subsequently, the samples were rapidly filtered and the radioactivity on the filter determined by liquid 
scintillation counting. Inhibition of radiolabelled llgand binding by the test compound was computed from 
maximal specific binding, determined with an appropriate excess of unlabelled sufentanil or DPDPE. IC50 
values were obtalnad by linear regression from plots relating Inhibition of the specific binding In probit units 
to the log of five diffarent Ilgand concentrations (9). In every case the correlation coefficient, r'-, of the Iog- 
prol04t plot was higher than 0.97. 
Iso4ated mouse vas defarens tmvd~ assav. The mvd assays were performed as previously described 
(11). Briefly, 1.5cm yes defarens segments from male, albino ICR mice were suspended in organ baths 
which contained 30mL of a modified Krebs' buffer (118mM NaCI, 4.75mM KCI, 2.54mM CaCI 2. 1.19mM 
MgSOA, 1.19mM KHgPO 4, 11mM glucose, 25mM NaHCOR, 0.3mM pargyllna HCI, 0.2mM tyrosina, 0.1mM 
ascorb]c acid, and (~.03mM sodium EDTA) saturated witR 95% 0 2 - 5% CO 2 and kept at 37°C. The 
segments were attached to strain gauge tmneducers and suspended between two platinum electrodes. After 
a 30mln equilibrium period, the segments were stimulated once every 10s with pairs of pulses of 2ms 
duration, 1 ms apart end at supramaxlmal voltage. Test compounds were evaluated for their ability to Inhibit 
the alectdcally stimulated smooth muscle contmctlona in this preparation. One vas deferens of each pair of 
vase defarentla was studied In the presence of either 100nM naltrexone or 100nM ICI-174864 and the other 
served as the control. IC¢,n values were determined by problt analysis and values reported are the means of 
3-9 detarmlnations. Because there were no appreciable differences among the IC£~2 values for the control 
preparations studied with either naitrexone or IC1-174864, the control IC,~. reported for each agonlst Is the 
mean of all control values determined in experiments with both antagonists. 
Results 
The binding affinitiss of eleven cyclic tetrapaptldes to p and ~; op4okl receptor~ln brain membranes as 
datermlned by the.abiflty of the test compounds to dlsp4ace the /= selective Ilgand [°H]sufentanll and the ~; 
selective ligand [°H]DPDPE (9) are listed I~ Tabie I. 4~Jso i~rovlded are the corresponding values for the 
reference p ligands sufentenU and [D-hJa , NMePhe , Gly°-ol]enkephelln (DAGO) and the reference 
llgand DPDPE. The Initial tetrapaptldes chosen for synthesis were those which had a carboxamlde terminal 
penlclllamlne residue, D-Cys or D-Pen as the second residue, and which were cyclized to either the disulfide 
or ethylene dlthloether. Such a sedes would allow direct compadson with both the dlsuffide-containlng 
pentapeptldes such as DPDPE as well as the highly # receptor selective cyclic tatrapeptide, Tyr-O-Orn-Phe- 
AspNH , reported by Schiller and coworkers (5,6) which, like the ethylene dithloathers, contains a 13- 
memi~'ed dng. Unlike the analogs reported here, however, Schlller's analog Is cydized via an amlde bond 
between the ornlthine 6-amino group and the aspartlc acid ~-carboxylate function. 
The carboxamlde terminal tet]apaptldes 1-7 end 9 display several Interesting features. Within this series, 
analogs ~-~ which have a L-Pen" residue, display rather low affinity and ere essentially devoid of receptor 
selectivity in the binding essay. In contrast c o ~ l n g  analogs with a D-Pen" residue (.t,2,Z and ~) 
exhibit considerable variation In both affinity and selectlv#y. For example, analogs 1 and Z show significant 
6 receptor selectivity with Z disp~aying considerable affinity for the 6 receptor. However, analog ~, which 
contains the same pdmary sequence as 7 but which is cyclized as the ethylene dlthioethar rather then the 
disuiffde, is significantly # receptor selective and displays a 2.4-fold higher affinity for # receptor binding 
sites then does the prototypioal , ligand, DAGO. The result of altering the dng size by two carbon atoms 
between analogs 7 and 9 Is a 130-fold shift in selectivity. 
The stdldng selecthdty shift seen between 7 and 9 as a result of altedng the dng size was further 
explored by preparing the methylene-dithloather (actually, a dithioacetal) analog, 8. and the propyfene- 
dlthloether analog, 10. Analogs Z-10 thus represent a subsedes In which primary sequence is maintained 
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TABLE I 
Oploid Receptor Binding ProBes of Cyclic Tetrapeptides 
IC50(nM) IC50~)  
Analog [3H] sufentanil 13H] DPDPE IC50(6 ) 
1 Tyr-D-P~en-~P~enNH 2 1320 61 21.6 
S-(CH2)2- ,S 
2 Tyr-D-PLn-Phe-D-P lenNH2 1580 215 7.35 
S S 
3 Tyr-D-plen-Phe-L-P lenNH2 188 103 1.83 
- ~-(CH2)2-~ 
4 /yr-D-Pen-Phe-L-PenNH 2 679 632 1.07 
S S 
5 Tyr-D-C~/s-Phe-L-P ~enNH2 350 373 0.94 
S-(CH2)2-S 
(~ Tyr-D-C~s-Phe-L-Pe~nNH2 294 222 1.32 
Z Tyr-D-C~/s-Phe-D- NH 2 320 17.2 18.6 
S E C H 2 ~ S  
Tyr-D-C~ s-Phe-D-PJnNH2 76 238 0.32 
S-(CH2)2-S 
Tyr-D-C~ s-Phe-D-P lenNH2 5.6 39.6 0.14 
S-(CH2)3-S 
10 Tyr-D-C~i~'-Phe-D-P~nNH 2 22.4 193 0.12 
1/ Tyr-D-C~s-Phe-D - nOH 1210 1.90 637 
DPDPE 7720 6.44 1200 
DAGO 13.2 690 0.02 
Sufentanll 1.3 45 0.03 
Binding assays were performed on rat brain membrane preparations as described in Methods. Reported 
IC50 values represent the mean of 1-6 experiments run in duplicate with 5 different concentrations of each 
compound. The average range (n < 4) or standard deviation (n ~ 4) for the/= and 8 selective assays was 
_+ 6.5% and +_ 10%, respectively (9). 
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while ring size Is vaded from an 11 -mernbered ring to a 14-membered dng. Increasing the dng size from the 
11 -membered dng In 7 to the 12-membered ring of 8 Increases p receptor affinity 4-fo~d while decreasing 6 
receptor affinity by a factor of 14 (Table I). As a result, analog 8 exhibits a slight binding preference for # 
opioid receptors. Increasing the dog size by an additional carbon results in a slight improvement in # 
receptor selectivity for analog 9 as compared with analog 8. Accompanlng this Improved selectivity are 
impressive 6-fold and 13-fold enhancements In 6 and # receptor binding affinities, respectively. Further 
expanding the ring size to the propylene-dithioether, 10, has little effect on selectivity but results in a 4-fold 
reduction in binding affinity. 
The results obtained with analogs .~4,~and ~, which contain 13-membered ring systems, are quite 
different from those observed for Schlller's analogous tetrapaptide. In the current series analogs 4 and 
which like Schiller's contain an L-amino acid in position 4, show very weak binding affinity and are essentially 
nonselective. Only analog 9 among those with a 13-membered ring displays /~ receptor binding selectivity 
and this salectlvity Is modest. The high # affinity of this analog is nonetheless Indicative of a favorable 
conformation for # receptor binding. That the analogs presented here differ In binding profile from those 
reported by Schiller is not surprising given the different stedc and electronic characteristics expected for 
these analogs. 
The significant 6 receptor selectivity of analogs 1 and 7 and the relatively high ~ receptor affinity of the 
latter are reminiscent of eadiar results in the pantapaptlde panicillamine~ontalnlng enkephalln series in which 
carboxamlde terminal analogs were obsecved to display 6 receptor selectivity (12). Since carboxylic acid 
terminal enkephalin analogs are generally ~ e d  to exhibit considerably enhanced 6 selectivity, the 
results obtained for analogs ! and Z suggested that the corresponding carboxyllc acid terminal analogs, 
particularly that of analog 7. might lead to greatly Improved 6 selectivity and/or binding affinity. As shown in 
Table I this is In fact the case; analog 11 shows greatly Improved 6 receptor salectivlty and affinity 
compared to analog 7. Indeed, analog 11 is almost as selective as DPDPE, the current standard for 6 
receptor selectivity, and has 3.5-fold higher affinity for 6 receptors. 
The oploid tetrapeptldes were further evaluated on the isolated, electrically stimulated mouse vas 
deferens preparation and were compared to DAGO and DPDPE (Table ll). Both DAGO and DPDPE were full 
agonists in this assay with DPDPE exhibiting approximately 15-fo~d higher potency then DAGO. All but three 
of the tetrapeptldes were full agonists which produced complete inhibition of the twitch. Analogs 2, 4, and 10 
were partial agonlsts which produced maximal Inhibitions of 85.1 + 2.1%, 65.8 _+ 3.8%, and 91.9 -+ 2.0%, 
respectively. The most potent in this sedes in inhibiting the twitch was analog 11 which was essentially 
equlpotent with DPDPE. Analog 9 had about one-half the potency and analog 8, about one-eighth the 
potency of DPDPE. All other analogs were less potent then DAGO as agonlsts in this preparation, and the 
partial agonlsts, analogs 2 and 4 were the least potent of the series. Because of the much lower potency of 
analog 2 on the vas deferans then in the binding assay, this paptide was evaluated as a possible antagonist, 
however no such activity was observed. 
In on:let to determine the types of opioid receptors which mediate the agonlst activity of the tetmpeptlde 
analogs, complete concentration-effect relationships were determined In the presence and absence of two 
oplofd antagonists, naltrexone, which is somewhat more salective for /~ receptors then for 6 receptors In the 
mouse vas deferens (11), and IC1-174864, which Is a highly selective antagonist at ~ oploid receptors and is 
virtually devoid of activtty at /~ receptors (13). Naltrexone (100nM) caused a 27.4-fold shift to the right in the 
DAGO concentration-effect curve which is typical of those shifts seen with highly selective # receptor 
agonlsts (14). In the presence of 100nM IC1-174864, there was no shift in the DAGO concentration-effect 
curve. In contrast, naltrexone produced a smaller shift In the DPDPE cormentration-effect curve (7.1-fold), 
and IC1-174864 sJgnlficantly shifted the DPDPE concentration-effect curve to the right (2.8-fo~d). 
Three of the tetrapaptlde analogs appeared to be even more selective then DPDPE for 6 receptors in 
the mouse vas deferens. TI~ shifts produced by 100nM naltrexone and 100nM IC1-174864 were 5.7- and 4.5- 
fold for analog 11, 3.2 and 4.8-fold for analog !, and 3.9- and 4.0-fo~d for analog 7. respectively. These 
results are In qualitative agreement with the discdacament studies which found these analogs to exhibit the 
highest 6 binding selectivity In the series. Two of the tetrapaptlde analogs appeared to act only on p 
recel~ors in the vas deferens. The shifts produced by 100nM naltrexone and 100nM IC1-174864 were 5.2- 
and 1.0-fold for analog 10 and 41.3- and 1.2-fold for analog 9. Again these results are In agreement with the 
displacement results which established analogs 9 and 10 as hevlng the highest # binding selectivity In this 
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TABLE II 
Tetrapeptlde Potancles In the Mouse Vas Defefens Preparation 
In the Presence and Absence of Oplold Antagonists 
IC50(nM) (_+ s.e.m.) 
Control + Naltrexone + IC1-174864 
Analog (100nM) (100nM) 
S S 
i Tyr'-D-plen-Phe-D'-plenNH2 409 + 140 1290 _+ 430 1950 + 968 
S-(CH2)2-S 
2 Tyr-D-PLn-Phe-D-P~nNH 2 4600 _+1050 7830 _+ 130 7030 _+ 20 
S S 
3 Tyr-D-PLn-Phe-L-P~NH 2 524 -+ 120 6370 -+2410 2910 -+1620 
~-(CH2)2- ~ 
4 Tyr-D-Pen-Phe-L-P6nNH 2 1630 _+ 230 * * 
$ S 
5 Tyr-D-CJys-Phe-L-PelnNH2 919 + 276 1650 -+ 107 2910 -+ 780 
S-(CH2)2-S 
§ Tyr-D-C~-Phe-L.-PlenNH2 371 + 96 947 -+ 41 452 _+ 108 
Z Tyr-D-C~I -Phe-D - nNH 2 120 _+ 24 469 _+ 130 477 _+ 143 
S ~ C H 2 ~  f 
8 Tyr-D-C!ys..Phe-D-PenNH2 46 _ 6 405 _+ 285 95 _+ 11 
S-(CH2)2-S 
9 Tyr-D-clys-Phe-D-plenNH2 11 _+ 3 435 _+ 136 12 +_ 4 
S-(CH2)3- L 
10 Tyr-D-C~-Phe-D-P NH 2 119 _+ 24 622 _+ 211 119 _+ 30 
1.~1 Tyr-D-C~/s-Phe-D-PonOH 4.6 _+ 0.5 26 _+ 6 21 -+ 5 
DPDPE 5.5 -+ 3 39 -+ 16 15 _+ 3 
DAGO 81 + 12 2230 -+ 446 73 -+ 17 
* Due to low potency and large shift by both antagonists, accurate IC50 values could not be determined. 
Each reported IC50 value represents the mean of 3-9 determinations. 
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series. Both antagonists shifted responses to analog 4 to such a degree that IC50 values could not he 
rellabiy determlnad, while naither antagonist produced an appreciable shift In the concentration-effect curve 
of analog 2. Both of these analogs were partial agonlsts of extrame/y low potency. The Interactions with the 
two antagonists suggested that the remaining tetmpeptides had significant activity at both p and 6 
receptors, which, again, is consistent with the results of the binding assays. 
Discuesk;ql 
As noted above analogs 3-~ which have a carboxy terminal L-Pen resldye, have low opioid binding 
affintty and are essentially nonselective. In contrast, the corresponding D-Pen" analogs display significant 
receptor selectivity and, except for ;~, have higher binding affinities. This Is particularly evident In analog Z, 
which has p receptor binding affinity like that of analog 5 but which has 6 receptor blndlog affinity 22.-fold 
higher than 5. Similarly, analog 9 has 5.6 and 53-fo/d higher affinity than analog 6 for S and p receptors, 
respectively. Potencies In the mvd assay parallel the binding results, with analog 7 exhibiting 7.7-fo4d higher 
potency than 5 and analog 9 disp/aying 35Jold higher potency than 6. Further, while analogs 5 and 6 are 
relatively nonselective based on antagonist shifts In the mvd, analog Z appears to be selective for ~ and 
analog ~ selectlva for /J receptors in this preparation. These findings suggest a requirement for a carboxy- 
terminal D-amino acid for optlmel binding to both 6 and /= receptors In this series, a more stringent 
condition than Is found In the penlclgamine-contalnlng pentapeptide series (1-3). Such a divergence of effect 
due to altering the configuration of the carboxy terminal residue may be due to the Increased rigidity resulting 
from the elimination of the glyclne residue in the tetrapeptlde series. In the pentapaptide sedes this flexible 
glycine residue has been suggested to serve as a means of achieving a similar topography for the various 
analogs In the series (15). The lack of such a flexible hinge In the tetrapeptide series eliminates much of this 
conformatlonal compensation. 
The changes in receptor binding selectivity observed among analogs Z-.I_~ In which the flng size is 
varied from 11- to 14-rnembered without altedng the pdmary sequence, also reflect the Importance of 
conformation on pharmacological activity. As was seen In a sedes of dithicether-contalnlng pentapeptides 
derived from DPDPE and DPLPE, increasing the ring size in the tetrapaptide series diminishes 6 receptor 
selectivity (4). In the pentapeptide series, however, this resulted from a large decrease In 6 receptor affinity 
with little effect observed on p receptor affinity. By contrast, In analogs 7-10 increasing ring size leads to 
greatly enhanced p, receptor binding affinity (and consequent p receptor selectivity), particularly In 9, while 
6 receptor affinity Is more varlabie. Nonetheless, the general trend previously observed, namely that more 
compact conformations tend to favor 6 receptor binding selectivity, is supported by the data presented 
here. The observed changes In binding selectlvltles In analogs 7-10 are in agreement wtth the behavior of 
these analogs In the mvd preparation. As seen from the antagonist shifts presented in Table II, analog 7 
displays high 6 selectivity in the mvd while 9 and 10 act prtmanly on # receptors in this assay. 
We have previously proposed that the high 6 receptor selectlvi~y of DPDPE is due In part to adverse 
steric Interactions between the ~, ~-dlmethyt substituents of the Pen': residue and the receptor binding site 
which decrease binding affinity to ~ and particularly to p receptors (4,15). Further evidence is seen In the 
current series from a comparison of binding affinities of analog 2 with analog 9. In these ethylene-dithloether 
analogs, analog 2, which has a D-Pen residue in position 2, has 5.4-fold and 280-fold lower affinity at o ~ and 
/J receptors, respectively than does analog 9. This result, which is similar to ! p t  observed with the 
pentapeptides, DPDPE and DCDPE, reflects adverse sterlc Interactions of the D-Pen 8,/3-dlmathyt groups 
particularly at /J receptor binding sites. It should be noted that the disulfide-containing analogs .1. and 7 
show a much less impressive steric effect due to the side chain of residue 2. In this case the /~, .8-dimethyls 
of residue 2 in analog .1_ result in approximately 4-fold reductions In binding affinity to both 6 and p 
receptors. In both analogs, p receptor binding affinities are low suggesting that these more compact 
structures may lead to adverse steric (or other) interactions with the p receptor which are not observed in 
more extended structures such as 9. 
The design of analog 11 was, as Indicated above, straightforward given the observed 6 receptor 
selectMty and potency of the carboxamlde terminal analog Z. The resulting high selectivity (similar to that of 
DPDPE) and high ~ affinity (3.5 folcl higher than that of DPDPE) dismayed by analog 11 are Impressive. The 
Improved affinity may prove to be useful for In ~lvo experiments. Perhaps of greater significance, analog 11 
provides an Important tool for elucidating the optimal ligand conformation for 5 opiokl receptor binding. 
Since both 11 and DPDPE must assume simgar conformations at the 6 binding site, comparisons of poesibie 
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conformations for these two compounds should allow the elimination of unlikely binding conformations and 
greatly facilitate the determination of the optlrnal ligand conformation at the ~ opiold receptor. 
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